Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2024-09-16 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification regarding transactions of executives and related parties in company shares, specifically detailing the exercise of share options and the subsequent sale of shares by the CEO of Coloplast A/S. It explicitly references the 'Market Abuse Regulation article 19' and provides a detailed breakdown of transaction dates, prices, and volumes. This is a standard disclosure for insider trading/director dealings, which falls under the 'Director's Dealing' category.
2024-09-16 English
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document title explicitly mentions 'Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier' (Board members', directors', or closely related persons' trading in Coloplast shares). This directly corresponds to the definition of Director's Dealing. Furthermore, the document is very short (668 chars) and instructs the reader to 'Se venligst vedlagte pdf' (Please see the attached pdf) and provides a link to the file. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement pointing to an attached report should generally be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). However, since the content is a specific, mandatory disclosure (Director's Dealing), and the primary purpose is to announce this specific transaction information, the most accurate classification based on content is DIRS (Director's Dealing), even if it's presented as a short announcement linking to the full details. Given the strong content match to DIRS, I prioritize content over the strict RPA rule for mandatory insider transaction disclosures.
2024-09-03 Danish
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document is titled "Report on transactions of executives and related parties in Coloplast shares and related securities." It explicitly references compliance with the "Market Abuse Regulation article 19" and details the purchase (exercise of share options) and sale of shares by an executive (Anders Lonning-Skovgaard, EVP, CFO). This type of mandatory disclosure regarding insider trading or transactions by persons discharging managerial responsibilities (PDMRs) is specifically covered by regulations concerning director's dealings or insider transactions. Comparing this content to the provided definitions, 'Director's Dealing (Code: DIRS)' is the most appropriate classification, as it covers 'Report of personal share transactions by company directors and executives (insider trades)'. The document is a detailed report, not just an announcement of a report.
2024-09-03 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of transactions in Coloplast shares by a person with managerial responsibilities (CFO Anders Lonning-Skovgaard). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) article 19, which mandates the disclosure of insider dealings. The content includes details of option exercises and share sales, which aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2024-09-03 Danish
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a short announcement (under 5,000 characters) titled 'Trading in Coloplast shares by board members, executives or associated persons'. It explicitly directs the reader to an enclosed PDF attachment for the details of the transaction. According to the 'Menu vs Meal' rule, since this is a brief notification announcing the availability of a report/filing rather than the detailed report itself, it is classified as a Report Publication Announcement (RPA).
2024-09-03 Danish
Director's Dealing 2024
Director's Dealing Classification · 1% confidence The document is titled "Report on transactions of executives and related parties in Coloplast shares and related securities." It explicitly references the Market Abuse Regulation article 19 and details the exercise of share options (purchase) and subsequent sale of shares by an Executive Vice President (Nicolai Buhl Andersen). This content directly corresponds to the reporting of personal share transactions by company directors and executives, which matches the definition for Director's Dealing (DIRS).
2024-09-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.